|
RAB21 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.726000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.677950E-01 |
| Normal-vs-Stage2 |
3.237600E-01 |
| Normal-vs-Stage3 |
1.474760E-01 |
| Normal-vs-Stage4 |
1.337650E-03 |
| Stage1-vs-Stage2 |
6.648500E-02 |
| Stage1-vs-Stage3 |
2.115500E-02 |
| Stage1-vs-Stage4 |
7.9123999999986E-05 |
| Stage2-vs-Stage3 |
9.141200E-01 |
| Stage2-vs-Stage4 |
2.222600E-01 |
| Stage3-vs-Stage4 |
2.005600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.244400E-01 |
| Normal-vs-AfricanAmerican |
3.999900E-04 |
| Normal-vs-Asian |
8.721800E-01 |
| Caucasian-vs-AfricanAmerican |
7.166000E-04 |
| Caucasian-vs-Asian |
9.545800E-01 |
| AfricanAmerican-vs-Asian |
1.976800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.143550E-02 |
| Normal-vs-Female |
5.475600E-02 |
| Male-vs-Female |
6.01709999999978E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.393800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.393400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.312200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.213800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.098000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.217700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.422800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.994450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.365600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.444000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.584600E-01 |
| Normal-vs-Grade 2 |
6.996100E-02 |
| Normal-vs-Grade 3 |
1.107790E-01 |
| Normal-vs-Grade 4 |
5.27279999662511E-08 |
| Grade 1-vs-Grade 2 |
6.277000E-01 |
| Grade 1-vs-Grade 3 |
7.586000E-02 |
| Grade 1-vs-Grade 4 |
2.369800E-04 |
| Grade 2-vs-Grade 3 |
2.404600E-03 |
| Grade 2-vs-Grade 4 |
3.98370003651394E-10 |
| Grade 3-vs-Grade 4 |
1.410730E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.01699999994254E-07 |
| Normal-vs-ccB subtype |
2.969300E-04 |
| ccA subtype-vs-ccB subtype |
1.58095758706622E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.796800E-01 |
| Normal-vs-N1 |
6.438000E-02 |
| N0-vs-N1 |
1.616640E-01 |
|
|
